GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » EV-to-Revenue

Feng Chi Biotech (ROCO:6744) EV-to-Revenue : 0.82 (As of May. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Feng Chi Biotech's enterprise value is NT$148.6 Mil. Feng Chi Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$180.6 Mil. Therefore, Feng Chi Biotech's EV-to-Revenue for today is 0.82.

The historical rank and industry rank for Feng Chi Biotech's EV-to-Revenue or its related term are showing as below:

ROCO:6744' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.28   Med: 0.98   Max: 2.6
Current: 0.82

During the past 8 years, the highest EV-to-Revenue of Feng Chi Biotech was 2.60. The lowest was 0.28. And the median was 0.98.

ROCO:6744's EV-to-Revenue is ranked better than
89.02% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs ROCO:6744: 0.82

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), Feng Chi Biotech's stock price is NT$23.00. Feng Chi Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$11.68. Therefore, Feng Chi Biotech's PS Ratio for today is 1.97.


Feng Chi Biotech EV-to-Revenue Historical Data

The historical data trend for Feng Chi Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech EV-to-Revenue Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 1.81 1.34 0.84 0.44 0.82

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 - 0.44 - 0.82

Competitive Comparison of Feng Chi Biotech's EV-to-Revenue

For the Biotechnology subindustry, Feng Chi Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feng Chi Biotech's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's EV-to-Revenue falls into.



Feng Chi Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Feng Chi Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=148.559/180.578
=0.82

Feng Chi Biotech's current Enterprise Value is NT$148.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Feng Chi Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$180.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feng Chi Biotech  (ROCO:6744) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Feng Chi Biotech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=23.00/11.682
=1.97

Feng Chi Biotech's share price for today is NT$23.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was NT$11.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feng Chi Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Feng Chi Biotech (ROCO:6744) Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines